Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a robust pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and accessing a pipeline of projects.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from the strong pipeline of life sciences developments.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, focusing on life sciences projects that have been deferred or abandoned.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from their expertise.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of developments.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from their expertise.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, particularly in light of Amgen's $1.0 billion expansion and other major developments.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into this market by partnering with developers like Longfellow Real Estate or King Street Properties to co-GP on new life sciences projects.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor/operator at the GP level, focusing on co-GP or JV equity to capitalize on growth opportunities.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor/operator at the GP level to share in the promote and access a pipeline of investment opportunities.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor/operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to capitalize on growth.

Co-GP / Platform:A family office could deploy into this market by backing a local life sciences operator at the GP level to share in the promote and benefit from their established networks.

Co-GP / Platform:A family office could deploy into the Raleigh life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from the region's strong growth trajectory.

Co-GP / Platform:A family office could deploy into the Raleigh life science market by backing a sponsor/operator at the GP level to share in the promote and benefit from a repeatable pipeline.